Tremelimumab combined with durvalumab in patients with...

The Lancet Respiratory Medicine 2018 / 06 Vol. 6; Iss. 6

Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study

Calabrò, Luana, Morra, Aldo, Giannarelli, Diana, Amato, Giovanni, D'Incecco, Armida, Covre, Alessia, Lewis, Arthur, Rebelatto, Marlon C, Danielli, Riccardo, Altomonte, Maresa, Di Giacomo, Anna Maria,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Language:
english
Journal:
The Lancet Respiratory Medicine
DOI:
10.1016/S2213-2600(18)30151-6
Date:
June, 2018
File:
PDF, 303 KB
english, 2018
Conversion to is in progress
Conversion to is failed